Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRUDENTIAL FINANCIAL INC Director's Dealing 2023

Jan 10, 2023

30092_dirs_2023-01-10_6ada22a9-31cb-43a9-a62f-80381686249c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PRUDENTIAL FINANCIAL INC (PRU)
CIK: 0001137774
Period of Report: 2023-01-01

Reporting Person: Feeney Caroline (Executive Vice President)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 5126 Direct
Common Stock 7541 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
2017 Employee Stock Option (Right to Buy) $110.45 2027-02-14 Common Stock (2117) Direct
10/2/17 Employee Stock Option (Right to Buy) $107.28 2027-10-02 Common Stock (1222) Direct
2018 Employee Stock Option (Right to Buy) $106.89 2028-02-13 Common Stock (2926) Direct
2019 Employee Stock Option (Right to Buy) $93.36 2029-02-12 Common Stock (5016) Direct
2020 Employee Stock Option (Right to Buy) $95.87 2030-02-11 Common Stock (7883) Direct
2020 Performance Share $ Common Stock (8762) Direct
6/12/2018 Employee Stock Option (right to buy) $99.76 2028-06-12 Common Stock (397) Direct
2021 Performance Shares $ Common Stock (12035) Direct
2021 Restricted Stock Units $0 Common Stock (3439) Direct
2022 Performance Shares $ Common Stock (15578) Direct
2022 Restricted Stock Units $0 Common Stock (6677) Direct
1/12/21 Restricted Stock Units $ Common Stock (60761) Direct

Footnotes

F1: The options vest in three equal annual installments beginning on February 14, 2018

F2: The options vest in three equal annual installments beginning on October 2, 2018

F3: The options vest in three equal annual installments beginning on February 13, 2019.

F4: The options vest in three equal annual installments beginning on February 12, 2020.

F5: The options vest in three equal annual installments beginning on February 11, 2021.

F6: Represents the target number of shares to be received relative to the Company's average ROE goals and relative to the ROE achievement of certain life insurance peer companies for the 2020 through 2022 performance period. The actual number of shares to be received will be determined by the Compensation Committee in February 2023.

F7: The performance shares convert to common stock on a 1 to 1 basis.

F8: The options vest in three equal annual installments beginning on June 12, 2019.

F9: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2024 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2021 through 2023 performance period, as adjusted based on the results of an inclusion and diversity modifier.

F10: Performance shares convert to common stock on a 1 to 1 basis

F11: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2022.

F12: The Restricted Stock Units convert to common stock on a 1 to 1 basis.

F13: Represents the target number of shares to be received. The actual number of shares to be received will be determined by the Compensation Committee in February 2025 based on the Company's ROE performance relative to certain life insurance peer companies and performance relative to a pre-determined goal for growth in adjusted book value per share for the 2022 through 2024 performance period.

F14: Performance shares convert to common stock on a 1 to 1 basis.

F15: The Restricted Stock Units will vest 1/3 per year beginning on February 28, 2023.

F16: The Restricted Stock Units convert to common stock on a 1 to 1 basis.

F17: The Restricted Stock Units will vest on 1/12/26